Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.
about
Neuroendocrine differentiation in prostate cancerCaV channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeuticsT-type calcium channels blockers as new tools in cancer therapiesT-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilageEpigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening.Transcriptional regulation of α1H T-type calcium channel under hypoxiaCytoskeleton reorganization as an alternative mechanism of store-operated calcium entry control in neuroendocrine-differentiated cells.Transthyretin is a key regulator of myoblast differentiation.Increased extracellular pressure stimulates tumor proliferation by a mechanosensitive calcium channel and PKC-β.Inhibition of T-type Ca²⁺ channels by endostatin attenuates human glioblastoma cell proliferation and migration.Functional chromaffin cell plasticity in response to stress: focus on nicotinic, gap junction, and voltage-gated Ca2+ channels.Ion channels as targets for cancer therapyIon channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis.Low-voltage-activated T-type Ca2+ channel inhibitors as new tools in the treatment of glioblastoma: the role of endostatin.T-type Ca2+ channels and the urinary and male genital tracts.Recent patents on calcium channel blockers: emphasis on CNS diseases.Conceptual approaches for treatment of phosgene inhalation-induced lung injury.CACNA2D2 promotes tumorigenesis by stimulating cell proliferation and angiogenesis.Thyroid hormone-dependent epigenetic suppression of herpes simplex virus-1 gene expression and viral replication in differentiated neuroendocrine cells.Activity-dependent regulation of T-type calcium channels by submembrane calcium ionsNew insights on thyroid hormone mediated regulation of herpesvirus infections.Functional expression of voltage-gated calcium channels in human melanoma.Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.Staurosporine rapidly commits 3T3-F442A cells to the formation of adipocytes by activation of GSK-3beta and mobilization of calcium.Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels.Novel role of cold/menthol-sensitive transient receptor potential melastatine family member 8 (TRPM8) in the activation of store-operated channels in LNCaP human prostate cancer epithelial cells.The involvement of Cav3.2/alpha1H T-type calcium channels in excitability of mouse embryonic primary vestibular neurones.Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells.Proliferation of prostate cancer cells and activity of neutral endopeptidase is regulated by bombesin and IL-1beta with IL-1beta acting as a modulator of cellular differentiation.Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validationFunctional coupling between large-conductance potassium channels and Cav3.2 voltage-dependent calcium channels participates in prostate cancer cell growth.Calcium signaling and T-type calcium channels in cancer cell cycling.Induction of T-type calcium channel gene expression by chronic hypoxia.Voltage-dependent ion channel currents in putative neuroendocrine cells dissociated from the ventral prostate of rat.Exposure to cAMP and beta-adrenergic stimulation recruits Ca(V)3 T-type channels in rat chromaffin cells through Epac cAMP-receptor proteins.Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts.Developmental change of T-type Ca2+ channel expression and its role in rat chromaffin cell responsiveness to acute hypoxia.Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.Calcium and Nuclear Signaling in Prostate Cancer.
P2860
Q24657547-D1C64B5E-47E0-4DC1-929D-D2D1E541B3F0Q28078594-CEC307B7-DD78-439E-823E-27E3B1C4ED9DQ28306311-D8E3A42F-E993-4717-999B-6AD87CC54B85Q30277635-BA4DF570-C67D-44D1-95EA-AAE749624D0AQ30578389-9F66CF25-BD77-4D0D-B9CA-35649333E558Q33985960-D98B75F0-FADC-4975-8288-E703F2D93B5DQ34295379-3B3AC7C1-EABB-4270-900A-B23FC0F92DD5Q34438254-7184600B-8A3B-49FD-8EB5-E1D3229F787EQ34744321-C92DCE44-6AA2-46F2-88D6-C3405DEB9417Q35806374-03624E33-0C95-4DAF-A0B8-871804BE61FFQ36159016-80DB1C24-DB05-47FA-ACEA-1A2E727004DFQ36876604-D674EE94-245E-4198-9810-72FC1EBD4A3FQ37901394-6423BC59-049A-42DD-A02A-96EDF534E2BEQ37937313-B6B58CD4-C1B7-41D4-8C77-429678577955Q38177193-C594D0CC-21E5-4806-A39D-5D076EC5DE3DQ38181909-4F541EBC-B57C-4EFD-AEEB-E272FC6CF2FCQ38239508-411670DC-B463-486D-B3DF-2D40F0BD04B9Q38420382-EA45E4F3-4078-4ED6-A3FB-DBD3E314349EQ38916632-29211946-272B-4F89-93A0-7845502DB283Q38961062-D1E1BA04-4E34-49CD-AABC-7A315E9D53E8Q39008538-7B313AB8-D37C-42CF-8146-85F3F3EF8D98Q39201654-39AB728D-D791-4D51-BFE5-1CDAF1754D8AQ39409759-08A8E91A-C079-418D-9635-33C301AF5AF4Q39875520-97150A9A-864E-48CD-9327-8DAE14EA10C6Q39973612-D9A034D8-14A6-4757-B33F-BF155265908EQ40205455-18A09329-BB1C-4673-B64C-3F401C5ADC32Q40370834-B6C0A0F7-4C0A-4EA1-B3A4-8C3F99EA0CC7Q40408433-AA470C5F-B33C-4CC7-A05F-6BAF6BDC1738Q40605826-FA508152-4B53-42C6-BCA4-D029E3021E43Q40607730-F231A58E-988B-435D-BB13-D7B4CE653679Q41533087-97823BAA-67BC-4578-B31C-D6092C118246Q42134273-EB68951D-BD93-4EA6-9EFE-10F291E9DE5FQ42553814-EBECCA77-900F-406D-822C-36CAB2A2270BQ44392728-BB9B6602-2DA9-4C13-8551-B2314740EB97Q44400278-AEE08290-61FF-460B-BBD8-5A0C0D41C2B4Q44888138-FD2C223D-2CD0-4FA8-8BAB-B5ECBAA5B7B0Q44921188-04F83365-4FE7-49F1-8ABF-DA65C51096C3Q46094270-E04FAF56-EC96-4903-9761-477BFD6F89FAQ51777015-E8AA1C7F-8CE2-4762-B0D6-C688BA08D924Q52578386-9AEB9D33-9D24-409F-ABB8-E23BF62E94A7
P2860
Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Overexpression of an alpha 1H ...... f human prostate cancer cells.
@ast
Overexpression of an alpha 1H ...... f human prostate cancer cells.
@en
Overexpression of an alpha 1H
@nl
type
label
Overexpression of an alpha 1H ...... f human prostate cancer cells.
@ast
Overexpression of an alpha 1H ...... f human prostate cancer cells.
@en
Overexpression of an alpha 1H
@nl
prefLabel
Overexpression of an alpha 1H ...... f human prostate cancer cells.
@ast
Overexpression of an alpha 1H ...... f human prostate cancer cells.
@en
Overexpression of an alpha 1H
@nl
P2093
P2860
P356
P1476
Overexpression of an alpha 1H ...... of human prostate cancer cells
@en
P2093
Karine Vanoverberghe
Michel F Rossier
Nathalie Lalevee
P2860
P304
10824-10833
P356
10.1074/JBC.M108754200
P407
P577
2002-01-17T00:00:00Z